MedPath
HSA Approval

CREDANIL 25/250 TABLET

SIN10286P

CREDANIL 25/250 TABLET

CREDANIL 25/250 TABLET

October 14, 1998

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Therapeutic

Prescription Only

Formulation Information

TABLET

ORAL

Medical Information

N04BA02

levodopa and decarboxylase inhibitor

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

CARBIDOPA MONOHYDRATE EQV CARBIDOPA

25 mg

Carbidopa

LEVODOPA

250 mg

Levodopa

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CREDANIL 25/250 TABLET - HSA Approval | MedPath